Afamin predicts the prevalence and incidence of nonalcoholic fatty liver disease.
Niina PitkänenArmin FinkenstedtClaudia LaminaMarkus JuonalaMika KähönenKari-Matti MäkeläBenjamin DieplingerAndre ViveirosAndreas MelmerIsabella LeitnerLudmilla KedenkoIlkka SeppäläJorma S A ViikariThomas MuellerFlorian KronenbergBernhard PaulweberTerho LehtimäkiHeinz ZollerOlli T RaitakariHans DieplingerPublished in: Clinical chemistry and laboratory medicine (2021)
Afamin concentrations are increased in patients with NAFLD and independently predict the development of NAFLD in a population-based cohort.
Keyphrases